Plasmodium falciparum RH5-interacting protein (PfRIPR)

Plasmodium falciparum RH5-interacting protein (PfRIPR) is a parasite-derived protein that forms part of an essential heterotrimeric complex—known as the RCR-complex—together with RH5 and CyRPA at the apical end of the malaria merozoite. RIPR is required for effective invasion of red blood cells, making it a critical target for therapeutic intervention. The protein is highly conserved and considered a high-priority vaccine candidate, as neutralizing antibodies targeting RIPR can inhibit parasite growth in vitro. Key inhibitory antibody epitopes cluster in its C-terminal EGF-like domains. While naturally acquired immunity rarely targets RIPR, its essential role in the parasite life cycle, poor natural immunogenicity, and lack of sequence polymorphism highlight its promise for rational vaccine design. RIPR's role is strictly as part of the invasion complex and does not resemble classical human drug targets such as GPCRs, ion channels, or enzymes. The canonical abbreviation is less prominent than for RH5, and "RH5-interacting protein" or "PfRIPR" are the most widely used names in the literature.

Other names

RH5-interacting proteinPfRIPRRH5IP

Monoclonal antibodies prevent parasite erythrocyte invasion by binding surface-exposed RIPR epitopes and neutralizing its function in the invasion complex. Vaccine candidates aim to elicit neutralizing antibodies targeting C-terminal EGF-like domains of RIPR.